framycetin has been researched along with Granuloma, Hodgkin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguilar, LK; Brenner, MK; Carrum, G; Gresik, MV; Grilley, B; Heslop, HE; Krance, RA; McClain, K; Rob, E; Rooney, CM; Roskrow, MA | 1 |
Bollard, C; Brenner, M; Carrum, G; Gahn, B; Gee, A; Gresik, M; Grilley, B; Heslop, H; Khan, S; Krance, R; Kuehnle, I; Popat, U; Przepiorka, D; Rooney, C | 1 |
Donner, L; Klener, P; Neuwirtová, R | 1 |
2 trial(s) available for framycetin and Granuloma, Hodgkin
Article | Year |
---|---|
Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease.
Topics: Anti-Bacterial Agents; Cell Line; Drug Resistance, Microbial; Feasibility Studies; Genes, Viral; Genetic Markers; Genetic Vectors; Herpesvirus 4, Human; Hodgkin Disease; Humans; Injections, Intravenous; Neomycin; Neoplasm Recurrence, Local; Retroviridae; T-Lymphocytes, Cytotoxic | 1998 |
Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.
Topics: Bone Marrow Transplantation; Cell Line; Drug Resistance, Neoplasm; Feasibility Studies; Female; Genetic Therapy; Herpesvirus 4, Human; Hodgkin Disease; Humans; Male; Neomycin; Recurrence; T-Lymphocytes, Cytotoxic | 2000 |
1 other study(ies) available for framycetin and Granuloma, Hodgkin
Article | Year |
---|---|
[Pimaricin therapy in mycotic complications of hemoblastosis].
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Drug Combinations; Female; Hodgkin Disease; Humans; Hydrocortisone; Leukemia; Lymphatic Diseases; Male; Middle Aged; Natamycin; Neomycin; Ointments; Stomatitis; Suppositories; Tablets; Time Factors; Vaginitis | 1972 |